Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic hematopoietic cell transplantation

There is no fulltext present in this item.

Title:	Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic hematopoietic cell transplantation
Author(s):	Sommer, Sebastian; Cruijsen, M.J.; Claus, R.; Bertz, H.; Waesch, Ralph; Marks, R.; Blijlevens, N.M.A. ; Velden, W.J.F.M. van der ; Finke, J. ; Lubbert, M.
Publication year:	2018
Source:	Leukemia Research, vol. 72, (2018), pp. 20-26
ISSN:	0145-2126
DOI:	https://doi.org/10.1016/j.leukres.2018.07.005
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : http://hdl.handle.net/2066/195441
Display more details
Subject:	All institutes and research themes of the Radboud University Medical Center Radboudumc 5: Inflammatory diseases RIHS: Radboud Institute for Health Sciences Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences
Organization:	Haematology
Journal title:	Leukemia Research
Volume:	vol. 72
Page start:	p. 20
Page end:	p. 26